Actively Recruiting
Evaluation of a Novel Point-of-Care Diagnostic Test for Human Papillomavirus (HPV)
Led by M.D. Anderson Cancer Center · Updated on 2025-11-10
600
Participants Needed
1
Research Sites
192 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
To learn if new HPV tests can provide the same results as standard HPV tests. The findings from this study may aid in the development of new HPV tests that require less equipment and are more accessible.
CONDITIONS
Official Title
Evaluation of a Novel Point-of-Care Diagnostic Test for Human Papillomavirus (HPV)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- People with a cervix 21 years of age or older
- Scheduled to undergo high-risk HPV testing at MD Anderson and The Harris Health System (LBJ Hospital) according to national and institutional guidelines at time of enrollment or anticipated to undergo LEEP, ECC, or biopsy
- Willing and able to provide informed consent
- Able to perform protocol-required activities and able to speak and read English or Spanish
You will not qualify if you...
- Patient or provider decision not to perform HPV testing (except for those undergoing LEEP, ECC, or biopsy)
- Participant or provider decision not to collect a sample for this study
- Participants who are pregnant
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
MD Anderson Cancer Center
Houston, Texas, United States, 77030
Actively Recruiting
Research Team
K
Kathleen Schmeler, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here